Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications
- PMID: 38167106
- PMCID: PMC10763319
- DOI: 10.1186/s13287-023-03620-0
Progress and application of adipose-derived stem cells in the treatment of diabetes and its complications
Abstract
Diabetes mellitus (DM) is a serious chronic metabolic disease that can lead to many serious complications, such as cardiovascular disease, retinopathy, neuropathy, and kidney disease. Once diagnosed with diabetes, patients need to take oral hypoglycemic drugs or use insulin to control blood sugar and slow down the progression of the disease. This has a significant impact on the daily life of patients, requiring constant monitoring of the side effects of medication. It also imposes a heavy financial burden on individuals, their families, and even society as a whole. Adipose-derived stem cells (ADSCs) have recently become an emerging therapeutic modality for DM and its complications. ADSCs can improve insulin sensitivity and enhance insulin secretion through various pathways, thereby alleviating diabetes and its complications. Additionally, ADSCs can promote tissue regeneration, inhibit inflammatory reactions, and reduce tissue damage and cell apoptosis. The potential mechanisms of ADSC therapy for DM and its complications are numerous, and its extensive regenerative and differentiation ability, as well as its role in regulating the immune system and metabolic function, make it a powerful tool in the treatment of DM. Although this technology is still in the early stages, many studies have already proven its safety and effectiveness, providing new treatment options for patients with DM or its complications. Although based on current research, ADSCs have achieved some results in animal experiments and clinical trials for the treatment of DM, further clinical trials are still needed before they can be applied in a clinical setting.
Keywords: Adipose-derived stem cells; Cell therapy; Complications; Diabetes mellitus; Diabetic wounds; Nephropathy; Retinopathy.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures


Similar articles
-
Diabetic microenvironment preconditioning of adipose tissue-derived mesenchymal stem cells enhances their anti-diabetic, anti-long-term complications, and anti-inflammatory effects in type 2 diabetic rats.Stem Cell Res Ther. 2022 Aug 19;13(1):422. doi: 10.1186/s13287-022-03114-5. Stem Cell Res Ther. 2022. PMID: 35986406 Free PMC article.
-
Treatment with adipose tissue-derived mesenchymal stem cells exerts anti-diabetic effects, improves long-term complications, and attenuates inflammation in type 2 diabetic rats.Stem Cell Res Ther. 2019 Nov 20;10(1):333. doi: 10.1186/s13287-019-1474-8. Stem Cell Res Ther. 2019. PMID: 31747961 Free PMC article.
-
Effects of adipose-derived stem cells plus insulin on erectile function in streptozotocin-induced diabetic rats.Int Urol Nephrol. 2016 May;48(5):657-69. doi: 10.1007/s11255-016-1221-3. Epub 2016 Jan 28. Int Urol Nephrol. 2016. PMID: 26820518
-
Transplantation of adipose derived stem cells in diabetes mellitus; limitations and achievements.J Diabetes Metab Disord. 2023 Aug 29;22(2):1039-1052. doi: 10.1007/s40200-023-01280-8. eCollection 2023 Dec. J Diabetes Metab Disord. 2023. PMID: 37975135 Free PMC article. Review.
-
Uncovering the link between diabetes and cardiovascular diseases: insights from adipose-derived stem cells.Can J Physiol Pharmacol. 2024 Apr 1;102(4):229-241. doi: 10.1139/cjpp-2023-0282. Epub 2024 Jan 10. Can J Physiol Pharmacol. 2024. PMID: 38198660 Review.
Cited by
-
Lacticaseibacillus paracasei Glu-07: A Promising Probiotic Candidate for the Management of Type 2 Diabetes Mellitus.Curr Microbiol. 2025 Jul 22;82(9):402. doi: 10.1007/s00284-025-04391-y. Curr Microbiol. 2025. PMID: 40694135 Free PMC article.
-
Recent Advances in Hydrogel Technology in Delivering Mesenchymal Stem Cell for Osteoarthritis Therapy.Biomolecules. 2024 Jul 17;14(7):858. doi: 10.3390/biom14070858. Biomolecules. 2024. PMID: 39062572 Free PMC article. Review.
-
The Effects of Acidified Nitrite on Wound Healing in Streptozotocin-Induced Diabetic Mice.Adv Biomed Res. 2024 Oct 28;13:97. doi: 10.4103/abr.abr_115_24. eCollection 2024. Adv Biomed Res. 2024. PMID: 39717258 Free PMC article.
-
Advancements in culture technology of adipose-derived stromal/stem cells: implications for diabetes and its complications.Front Endocrinol (Lausanne). 2024 Apr 12;15:1343255. doi: 10.3389/fendo.2024.1343255. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38681772 Free PMC article. Review.
-
The effect of adipose-derived mesenchymal stem cells against high fructose diet induced liver dysfunction and dysbiosis.Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):4525-4537. doi: 10.1007/s00210-024-03518-5. Epub 2024 Nov 5. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39500806 Free PMC article.
References
-
- Eirin A, Zhu X-Y, Krier JD, Tang H, Jordan KL, Grande JP, Lerman A, Textor SC, Lerman LO. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis. Stem Cells. 2012;30(5):1030–1041. doi: 10.1002/stem.1047. - DOI - PMC - PubMed
-
- Shah GN, Morofuji Y, Banks WA, Price TO. High glucose-induced mitochondrial respiration and reactive oxygen species in mouse cerebral pericytes is reversed by pharmacological inhibition of mitochondrial carbonic anhydrases: implications for cerebral microvascular disease in diabetes. Biochem Biophys Res Commun. 2013;440(2):354–358. doi: 10.1016/j.bbrc.2013.09.086. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources